PRF Technologies (PRFX) Consolidated Net Income (2020 - 2024)
PRF Technologies (PRFX) recorded quarterly Consolidated Net Income of -$7.3 million in Q2 2024, down 31.99% on a QoQ basis from -$5.6 million in Q1 2024, and down 236.77% year-over-year from $5.4 million in Q3 2023.
PRF Technologies (PRFX) Consolidated Net Income (2020 - 2024) Analysis & Trends
PRF Technologies has disclosed Consolidated Net Income across 5 years of filings, most recently posting -$7.3 million for Q2 2024.
- Quarterly Consolidated Net Income fell 236.77% year-over-year to -$7.3 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$7.3 million (up 55.41% YoY) and the FY2025 annual result came in at -$5.0 million, up 65.57% from the prior year.
- Consolidated Net Income fell to -$7.3 million in Q2 2024, from -$5.6 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$132000.0 in Q1 2020 and troughed at -$7.3 million in Q2 2024.
- A 5-year average of -$2.2 million and a median of -$1.8 million in 2021 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2021 — Consolidated Net Income slumped 1444.7% — and 2023, when it jumped 38.12%.
- Tracing PRFX's Consolidated Net Income over 5 years: stood at -$691000.0 in 2020, then slumped by 151.95% to -$1.7 million in 2021, then plunged by 87.02% to -$3.3 million in 2022, then dropped by 9.46% to -$3.6 million in 2023, then tumbled by 106.09% to -$7.3 million in 2024.
- Business Quant data shows PRFX's Consolidated Net Income at -$7.3 million in Q2 2024, -$5.6 million in Q1 2024, and -$3.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.35 Mn |
| Mar 31, 2024 | -5.57 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -2.33 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -691,000.00 |
| Sep 30, 2020 | -700,000.00 |
| Jun 30, 2020 | -148,000.00 |
| Mar 31, 2020 | -132,000.00 |